AI assistant
Sending…
Medistim — Director's Dealing 2022
Jan 19, 2022
3662_dirs_2022-01-19_36cdf268-9208-44d6-a5e2-5a5f61a44e78.html
Director's Dealing
Open in viewerOpens in your device viewer
Transfer of shares to CEO
Transfer of shares to CEO
Medistim ASA has transferred 12,000 shares to Medistim CEO Kari E. Krogstad, at the last traded share price in 2021, of 367.50 NOK per share. This is in accordance with her compensation agreement with the company, as described in the Company's Annual Report. After the transfer, Kari E. Krogstad holds a total of 63,802 shares in the company and Medistim ASA holds 96,422 own shares.
More from Medistim
Major Shareholding Notification
2026
May 12
Major Shareholding Notification
2026
May 12
Notice of Dividend Amount
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 6
Notice of Dividend Amount
2026
May 6
Notice of Dividend Amount
2026
Apr 30
Report Publication Announcement
2026
Apr 28